Page 398 - Read Online

Darbre. J Cancer Metastasis Treat 2019;5:58 I http://dx.doi.org/10.20517/2394-4722.2019.22 Page 11 of 13

10. Nair S, Sachdeva G. Estrogen matters in metastasis. Steroids 2018;38:108-16
11. Price JE, Zhang RD. Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev 1990;8:285-97.
12. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, et al. ER signaling through slug regulates E-cadherin and EMT. Oncogene
2010;29:1451-62.
13. Planas-Silva MD, Waltz PK. Estrogen promotes reversible epithelial-to-mesenchymal transition and collective motility in MCF-7
breast cancer cells. J Steroid Biochem Molec Biol 2007;104:11-21.
14. Li Y, Wang JP, Santen RJ, Kim TH, Park H, et al. Estrogen stimulation of cell migration involves multiple signaling pathway
interactions. Endocrinol 2010;151:5146-56.
15. Sanchez AM, Flamini MI, Baldacci C, Goglia L, Genazzani AR, et al. Estrogen receptor-promotes breast cancer cell motility and
invasion via focal adhesion kinase and N-WASP. Mol Endocrinol 2010;24:2114-25.
16. Kohrmann A, Kammerer U, Kapp M, Dietl J, Anaker J. Expression of matrix metalloproteinases (MMPs) in primary human breast
cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer 2009;9: 188.
17. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
18. Dian D, Heublein S, Wiest I, Barthell L, Friese K, et al. Significance of the tumor protease cathepsin D for the biology of breast cancer.
Histol Histopathol 2014;29:433-8.
19. Morisset M, Capony F, Rochefort H. The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease.
Biochem Biophys Res Commun 1986;138:102-9.
20. Takei H, Lee ES, Jordan VC. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-
receptor positive breast cancer. Breast Cancer 2002;9: 39.
21. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene encoding for the
potent angiogenic factor vascular endothelial growth factor. Cancer Res 2000;60:3183-90.
22. Dabrosin C, Palmer K, Muller WJ, Gaudlie J. Esradiol promotes growth and angiogenesis in polyoma middle T transgenic mouse
mammary tumor explants. Breast Cancer Res Treat 2003;78:1-6.
23. Dabrosin C, Margetts PJ, Gauldie J. Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine
mammary cancer. Int J Cancer 2003;107:535-40.
24. Office of National Statistics, England. Series MB1, Published Crown Copyright, London. from 1979 to 2014 (MBseries 1 numbered
to 43).
25. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;133:571-3.
26. Barr L, Metaxas G, Harbach CAJ, Savoy LA, Darbre PD. Measurement of paraben concentrations in human breast tissue at serial
locations across the breast from axilla to sternum. J Appl Toxicol 2012;32:219-32.
27. Byford JR, Shaw LE, Drew MGB, Pope GS, Sauer MJ, et al. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J
Steroid Biochem Molec Biol 2002;80:49-60.
28. Wright JV, Schliesman B, Robinson L. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant,
premenopausal women: a preliminary investigation. Alt Med Rev 1999;4:266-70.
29. Charles AK, Darbre PD. Combinations of parabens at concentrations measured in human breast tissue can increase proliferation of
MCF-7 human breast cancer cells. J Appl Toxicol 2013;33:390-8.
30. Khanna S, Dash PR, Darbre PD. Exposure to parabens at the concentration of maximal proliferative response increases migratory and
invasive activity of human breast cancer cells in vitro. J Appl Toxicol 2014;34:1051-9.
31. Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, et al. In vitro and in vivo estrogenicity of UV screens. Environ Health
Perspect 2001;109: 239-44.
32. Hoffmann K, Laperre J, Avermaete A, Altmeyer P, Gambichler T. Defined UV protection by apparel textiles. Arch Dermatol 2001;137:
1089-94.
33. Montes-Grajales D, Fennix-Agudelo M, Miranda-Castro W. Occurrence of personal care products as emerging chemicals of concern
in water resources: A review. Sci Total Environ 2017;595:601-14.
34. Barr L, Alamer M, Darbre PD. Measurement of concentrations of four chemical ultraviolet filters in human breast tissue at serial
locations across the breast. J Appl Toxicol 2018;38:1112-20.
35. Alamer M, Darbre PD. Effects of exposure to six chemical ultraviolet filters commonly used in personal care products on motility of
MCF-7 and MDA-MB-231 human breast cancer cells in vitro. J Appl Toxicol 2018;38:148-59.
36. Darbre PD. Aluminium and the human breast. Morphologie 2016;100:65-74
37. Exley C, Charles LM, Barr L, Martin C, Polwart A, et al. Aluminium in human breast tissue. J Inorg Biochem 2007;101:1344-6.
38. Mannello F, Tonti GA, Darbre PD. Concentration of aluminium in breast cyst fluids collected from women affected by gross cystic
breast disease. J Appl Toxicol 2009;29:1-6.
39. Mannello F, Tonti GA, Medda V, Simone P, Darbre PD. Analysis of aluminium content and iron homeostasis in nipple aspirate fluids
from healthy women and breast cancer-affected patients. J Appl Toxicol 2011;31:262-9.
40. Darbre PD. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the
human breast. J Appl Toxicol 2006;26:191-7.
41. Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem 2005;99:1912-9.
42. Darbre PD, Bakir A, Iskakova E. Effect of aluminium on migratory and invasive properties of MCF-7 human breast cancer cells in
culture. J Inorg Biochem 2013;128:245-9.
43. Bakir A, Darbre PD. Effect of aluminium on migration of oestrogen unresponsive MDA-MB-231 human breast cancer cells in culture.